Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8TTR

CA9 mimic bound to SH7

Summary for 8TTR
Entry DOI10.2210/pdb8ttr/pdb
DescriptorCarbonic anhydrase 2, ZINC ION, 4-{5-phenyl-4-[(4-sulfamoylphenyl)carbamamido]-1H-pyrazol-1-yl}benzene-1-sulfonamide, ... (7 entities in total)
Functional Keywordscarbonic anhydrase 9 mimic, inhibitor complex, lyase, lyase-inhibitor complex, lyase/inhibitor
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight30071.12
Authors
Peat, T.S. (deposition date: 2023-08-14, release date: 2024-11-27, Last modification date: 2024-12-11)
Primary citationEldehna, W.M.,Fares, M.,Bonardi, A.,Avgenikos, M.,Baselious, F.,Schmidt, M.,Al-Warhi, T.,Abdel-Aziz, H.A.,Rennert, R.,Peat, T.S.,Supuran, C.T.,Wessjohann, L.A.,Ibrahim, H.S.
4-(Pyrazolyl)benzenesulfonamide Ureas as Carbonic Anhydrases Inhibitors and Hypoxia-Mediated Chemo-Sensitizing Agents in Colorectal Cancer Cells.
J.Med.Chem., 67:20438-20454, 2024
Cited by
PubMed Abstract: Hypoxia in tumors contributes to chemotherapy resistance, worsened by acidosis driven by carbonic anhydrases (CA IX and XII). Targeting these enzymes can mitigate acidosis, thus enhancing tumor sensitivity to cytotoxic drugs. Herein, novel 4-(pyrazolyl)benzenesulfonamide ureas () were developed and evaluated for their inhibitory activity against CA IX and XII. They showed promising results (CA IX: = 15.9-67.6 nM, CA XII: = 16.7-65.7 nM). Particularly, demonstrated outstanding activity (s = 15.9 nM for CA IX and 55.2 nM for CA XII) and minimal off-target kinase inhibition over a panel of 258 kinases. In NCI anticancer screening, exhibited broad-spectrum activity with an effective growth inhibition full panel GI (MG-MID) value of 3.5 μM and a subpanel GI (MG-MID) range of 2.4-6.3 μM. Furthermore, enhanced the efficacy of Taxol and 5-fluorouracil in cotreatment regimens under hypoxic conditions in HCT-116 colorectal cancer cells, indicating its potential as a promising anticancer agent.
PubMed: 39550697
DOI: 10.1021/acs.jmedchem.4c01894
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.45 Å)
Structure validation

251174

PDB entries from 2026-03-25

PDB statisticsPDBj update infoContact PDBjnumon